Company news
Pulmonx Corporation news in 2024
Pulmonx Corporation's news releases, calls and decks from 2024, newest first.
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers
November 18, 2024
Pulmonx Reports Third Quarter 2024 Financial Results
October 29, 2024
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
October 15, 2024
Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024
September 8, 2024
Pulmonx Reports Second Quarter 2024 Financial Results
July 30, 2024
Pulmonx Reports First Quarter 2024 Financial Results
April 30, 2024
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
April 9, 2024
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
April 1, 2024
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
February 25, 2024
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
February 20, 2024
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
February 20, 2024
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
February 6, 2024